Blood Collection Kit Distribution Optimization
This project is operational in United States. The source does not give a quantified reduction for this project.
- Status
- Operational
- Estimated reduction
- Not quantified in the source
- Countries
- United States
- Sector
- Transport and logistics
- Announced
- Not stated
- Expected start
- Not stated
About this project
The description is as the source gives it.
Guardant Health optimized Blood Collection Kit (BCK) distribution by partnering with Contract Manufacturing Organization partners on both U.S. coasts, shortening freight distances and reducing greenhouse gas emissions from product transportation and distribution (Scope 3 upstream). Evidence: "Over the past year, we began implementing an initiative to optimize our Blood Collection Kit (BCK) distribution by switching to Contract Manufacturing Organization partners on both coasts of the U.S. ... which helps reduce costs, decrease risk of transportation disruptions, and decrease greenhouse gas emissions associated with our product transportation and distribution." — https://guardanthealth.com/wp-content/uploads/Guardant-Health_Corporate-Responsibility-Report_May-2025_Rev02.pdf
Statuses, countries and reductions are as the public source states them, and may be out of date.
Project developers can list this project on Carbon3
Project developers can list a project on Carbon3, so that buyers and co-funders can see it. Listing a project costs nothing.